November 5 - 7, 2015
Emory University Conference Center
Atlanta, GA

An increasing number of oncologists are focusing their clinical practices on the treatment of breast cancer, creating a need for specialized education. The School of Breast Oncology®, which has been held annually since 2003, was developed to advance patient care by providing a curriculum-based program focused exclusively on breast cancer clinical management. This intensive 3-day interactive program will provide a comprehensive review of data on the most important aspects of breast cancer biology, diagnostics, prevention and treatment, with lectures emphasizing clinical implications presented by leading clinical investigators. The School of Breast Oncology® not only provides a comprehensive overview for fellows or oncologists who are new to practice, but also serves as a valuable refresher course with updates on the latest data and changes to standards of care for the oncologist who has been in practice for several years or more.

This educational program is directed toward medical, radiation, and surgical oncologists whose primary practice focus is breast cancer and who intend to reinforce their knowledge base and expand their expertise in breast cancer diagnosis, treatment, and management. Participants will be primarily oncologists or fellows in training whose practice requires mastery and a critical understanding of the fundamental principles, pivotal published studies, and emerging information on the pathogenesis and management of breast cancer.

At the conclusion of this activity, participants should be better prepared to:

• Explain breast cancer pathology, prognostic/predictive markers, and tumor biology in the context of stratifying risk among patients with breast cancer
• Review accepted imaging and diagnostic standards for breast cancer
• Apply biomarkers, molecular assays, and other risk assessment tools to optimize clinical decision-making for the patient with breast cancer
• Explain evidence-based recommendations concerning the use of surgical, radiation, and medical therapies to manage breast cancer
• Discuss current approaches for the management of early stage or locally advanced breast cancer
• Incorporate personalized approaches concerning the use of systemic therapies for advanced forms of breast cancer
• Describe proactive strategies to mitigate the impact and occurrence of treatment related toxicities in the setting of breast cancer
• Identify patients with breast cancer for referral to a clinical trial

This activity is supported by educational grants from Astellas, Celgene Corporation, Eisai Inc., Genentech, Lilly, Novartis Pharmaceuticals Corporation, and PUMA Biotechnology.

For further information concerning Lilly grant funding visit www.lillygrantoffice.com.

Physicians' Education Resource^®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource^®, LLC designates this live activity for a maximum of 25.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity provides 4.25 Category I CME and self-assessment credits toward Part 2 of the ABS MOC Program. For more information, please visit www.absurgery.org/
default.jsp?exam-moccme


CONTINUING EDUCATION CREDIT (Pharmacists, Nurses, Nurse Practitioners, and Physician Assistants):
You will receive a certificate of attendance for the CME-certified sessions (those designated for AMA/PRA Category 1 Credits™) which may be submitted to state licensing boards for determination of credit reciprocity (conversion to CEUs).

Joyce O'Shaughnessy, MD
Celebrating Woman Chair in Breast Cancer Research
Baylor University Medical Center
Texas Oncology
Chair, Breast Cancer Research Program
The US Oncology Network
Dallas, TX